Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bedard

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Journal of Allergy and Clinical Immunology|November 1, 1989
Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitisJ Del Carpio, L Kabbash, Y Turenne, et al.
Vaccine|March 11, 2017
A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune responsePeter Probst, John B Grigg, Myra Wang, et al.
American Journal of Respiratory and Critical Care Medicine|January 5, 2000
Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndromeM O Meade, R J Cook, G H Guyatt, et al.
Scientific Reports|November 19, 2022
Lassa antiviral LHF-535 protects guinea pigs from lethal challengeKathleen A Cashman, Eric R Wilkinson, Jeffrey Posakony, et al.
Ecological Applications : a Publication of the Ecological Society of America|December 17, 2016
Movements of a deep-water fish: establishing marine fisheries management boundaries in coastal Arctic watersNigel E Hussey, Kevin J Hedges, Amanda N Barkley, et al.
Journal of Virology|December 18, 2015
Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR PathwaySowmya Pattabhi, Courtney R Wilkins, Ran Dong, et al.
Plos Pathogens|December 22, 2018
A potent Lassa virus antiviral targets an arenavirus virulence determinantIkenna G Madu, Megan Files, Dima N Gharaibeh, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Journal of Allergy and Clinical Immunology|November 1, 1989
Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitisJ Del Carpio, L Kabbash, Y Turenne, et al.
Vaccine|March 11, 2017
A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune responsePeter Probst, John B Grigg, Myra Wang, et al.
American Journal of Respiratory and Critical Care Medicine|January 5, 2000
Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndromeM O Meade, R J Cook, G H Guyatt, et al.
Scientific Reports|November 19, 2022
Lassa antiviral LHF-535 protects guinea pigs from lethal challengeKathleen A Cashman, Eric R Wilkinson, Jeffrey Posakony, et al.
Ecological Applications : a Publication of the Ecological Society of America|December 17, 2016
Movements of a deep-water fish: establishing marine fisheries management boundaries in coastal Arctic watersNigel E Hussey, Kevin J Hedges, Amanda N Barkley, et al.
Journal of Virology|December 18, 2015
Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR PathwaySowmya Pattabhi, Courtney R Wilkins, Ran Dong, et al.
Plos Pathogens|December 22, 2018
A potent Lassa virus antiviral targets an arenavirus virulence determinantIkenna G Madu, Megan Files, Dima N Gharaibeh, et al.
Pageof 4